Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New Podcast CE Alert: "Medications for Opioid Use Disorder" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources

Resources

  • Diabetes (919)
  • Endocrinology (11)
  • Hyperglycemia (40)
  • Hypoglycemia (19)
  • Other (32)
  • Prediabetes (5)
  • Resources (278)
    • Charts (57)
    • Guidelines (81)
    • Letters (3)
    • Natural Medicines / Supplements (4)
    • Patient Education (12)
    • PL Voices (159)
    • Quality Measures (40)
  • Thyroid Disorders (64)
211 - 225 of 278 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: AACE Diabetes Management Consensus Statement (2013). May 2010
Other: Senate Concerns about Avandia April 2010
Commentary: Avandia and Cardiovascular Safety: Ongoing Review April 2010
Commentary: Insulins March 2010
Commentary: New Drug: Victoza (Liraglutide) March 2010
Guideline: ADA Standards of Medical Care in Diabetes February 2010
Guideline: CDA Clinical Practice Guidelines on Monitoring Glycemic Control February 2010
Other: Pancreatitis and Byetta (Exenatide) November 2009
Commentary: New Drug: Onglyza (Saxagliptin) September 2009
Guideline: Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes (ADA, 2009) September 2009
Other: Sample Collaborative Practice Agreement August 2009
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Chart: Collaborative Drug Therapy Management (CDTM) August 2009
Guideline: HFSA 2006 Comprehensive Heart Failure Practice Guideline April 2009
Commentary: Selecting a Sulfonylurea April 2009
  • « Prev
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved